SHR6508

SHR6508 · Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SHR6508, covering 2023-06-18 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 1]

See pricing